𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A pilot study of thymus extract in chronic non-A, non-B hepatitis

✍ Scribed by M. P. CIVEIRA; A. CASTILLA; S. MORTE; M. SERRANO; J. PRIETO


Book ID
108602890
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
382 KB
Volume
3
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Treatment of chronic non-A, non-B hepati
✍ S. Chris Pappas; Dr. Jay H. Hoofnagle; Neal Young; Stephen E. Straus; E. Anthony πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 576 KB

Five patients with chronic non-A, non-B hepatitis were entered into a pilot therapeutic study of the antiviral agent acyclovir [9-(2-hydroxyethoxymethyl) guanine]. Each patient received acyclovir by slow intravenous infusion in a dosage of 5 mg/kg every 8 hr for 10 days. During therapy, serum aminot

Non-A, Non-B hepatitis; Factors involved
✍ A. Biglino; M. Depaoli; G. Cariti; D. Giacobbi; P. Gioannini πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 476 KB

A cross-sectional, longitudinal study was undertaken .on a group of acute non-A, non-B hepatitis patients, as well as on a control group of hepatitis B patients, in order to assess both the prevalence of the most important factors favoring infection, and the relevance ,of these factors in promoting

Non-A, non-b hepatitis in chimpanzees: I
✍ Dr. Daniel W. Bradley; James E. Maynard; Karen A. McCaustland; Bert L. Murphy; E πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 391 KB πŸ‘ 2 views

Two chimpanzees with persistent non-A, non-B (NANB) hepatitis were superinfected with marmoset-passaged MS-1 HAV. Two control chimpanzees were also infected with marmoset-passaged HAV. Neither animal with persistent NANB hepatitis developed elevated alanine aminotransferase (ALT) activity, whereas b